Gallo Eugenia, Pugi Alessandra, Lucenteforte Ersilia, Maggini Valentina, Gori Luigi, Mugelli Alessandro, Firenzuoli Fabio, Vannacci Alfredo
Altern Ther Health Med. 2014 Mar-Apr;20(2):13-7.
The Pharmacovigilance Center of the University of Florence conducted a survey across 3 hospitals in Tuscany (Empoli, Florence, and Prato) on a sample population consisting of 478 patients admitted to the hospital for a preoperative assessment before surgical intervention. The aim of the study was to assess the concomitant use of herbal remedies (HRs) and prescribed medications and to evaluate the most important potential interactions. Almost 50% of the patients surveyed-238 of 478 (49.8 %)-used at least 1 HR. Among them, 55 (23.1%) were actually exposed to at least 1 potential interaction. In particular, 42 participants had an HR-drug interaction and 17 participants had a dietary supplement drug interaction. A large percentage of patients undergoing surgery take HRs that could potentially interact with drugs administered perioperatively. Antihypertensive, antiplatelet, anticoagulant, and central nervous system (CNS) agents were the main products involved. The use of HRs is not devoid of risks and adverse effects due to potential interactions that may be serious or even lifethreatening. HR-drug interactions should be deeply investigated, especially in high-risk patient populations. Health care professionals should pay close attention and always investigate the consumption of HRs among their patients.
佛罗伦萨大学药物警戒中心对托斯卡纳的3家医院(恩波利、佛罗伦萨和普拉托)进行了一项调查,样本为478名因手术干预前的术前评估而入院的患者。该研究的目的是评估草药疗法(HRs)与处方药的联合使用情况,并评估最重要的潜在相互作用。近50%的受调查患者——478名中的238名(49.8%)——使用了至少一种HRs。其中,55名(23.1%)实际上暴露于至少一种潜在相互作用中。具体而言,42名参与者存在HR-药物相互作用,17名参与者存在膳食补充剂-药物相互作用。很大一部分接受手术的患者服用的HRs可能会与围手术期使用的药物发生相互作用。抗高血压药、抗血小板药、抗凝药和中枢神经系统(CNS)药物是主要涉及的产品。由于潜在的相互作用可能很严重甚至危及生命,HRs的使用并非没有风险和不良反应。应深入研究HR-药物相互作用,尤其是在高危患者群体中。医疗保健专业人员应密切关注,并始终调查其患者中HRs的使用情况。